N-Terminal Residues Control Proteasomal Degradation of RGS2, RGS4, and RGS5 in Human Embryonic Kidney 293 Cells

Regulator of G protein signaling (RGS) proteins modulate G protein-coupled receptor (GPCR) signaling. The N termini of some RGS4-family proteins provide receptor specificity and also contain an N-end rule determinant that results in ubiquitylation and decreased protein expression. The relevance of these mechanisms to other RGS proteins is not fully understood. Thus we examined function, receptor specificity, and expression of R4 subfamily RGS proteins (RGS2, -3, -4, -5, and -8). Although the N terminus plays a key role in protein stability in human embryonic kidney (HEK) 293 cells, we were unable to demonstrate specificity of RGS2, -3, -4, -5, or -8 for muscarinic receptors (M1, M3, and M5). However, cellular RGS activity (8 = 3 > 2) was strongly correlated with expression; RGS4 and -5 had minimal expression and activity. Stabilizing mutations of RGS4 and -5 (C2S) enhanced expression and function with a greater influence on RGS4 than on RGS5. We were surprised to find that a predicted destabilizing mutation in RGS8 (A2C) did not markedly affect expression and had no effect on function. In contrast, a destabilizing mutation in RGS2 (RGS2-Q2L) recently identified as a rare N-terminal genetic variant in a Japanese hypertensive cohort (J Hypertens 23:1497–1505, 2005) showed significantly reduced expression and inhibition of angiotensin II (AT1) receptor-stimulated accumulation of inositol phosphates. We were surprised to find that RGS2-Q2R, also predicted to be destabilizing, showed nearly normal expression and function. Thus, proteasomal regulation of RGS expression in HEK293 cells strongly controls RGS function and a novel RGS2 mutation with decreased protein expression could be relevant to the pathophysiology of hypertension in humans.

[1]  R. Neubig,et al.  Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay , 2007, Molecular Pharmacology.

[2]  A. Avogaro,et al.  Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II , 2006, Journal of hypertension.

[3]  P. Chidiac,et al.  RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. , 2006, Cellular signalling.

[4]  R. Neubig,et al.  Endogenous RGS Proteins and G&agr; Subtypes Differentially Control Muscarinic and Adenosine-Mediated Chronotropic Effects , 2006, Circulation research.

[5]  Wei Zhang,et al.  Selective Loss of Fine Tuning of Gq/11 Signaling by RGS2 Protein Exacerbates Cardiomyocyte Hypertrophy* , 2006, Journal of Biological Chemistry.

[6]  E. Eskin,et al.  Polymorphisms and Haplotypes of the Regulator of G Protein Signaling-2 Gene in Normotensives and Hypertensives , 2006, Hypertension.

[7]  Min Jae Lee,et al.  RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Varshavsky,et al.  The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators , 2005, Nature.

[9]  Y. Kokubo,et al.  Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population , 2005, Journal of hypertension.

[10]  C. Hague,et al.  Selective Inhibition of α1A-Adrenergic Receptor Signaling by RGS2 Association with the Receptor Third Intracellular Loop* , 2005, Journal of Biological Chemistry.

[11]  Richard R. Neubig,et al.  International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.

[12]  A. Tinker,et al.  Regulators of G-protein Signaling Form a Quaternary Complex with the Agonist, Receptor, and G-protein , 2005, Journal of Biological Chemistry.

[13]  S. Tovey,et al.  Single-Cell Imaging of Intracellular Ca2+ and Phospholipase C Activity Reveals That RGS 2, 3, and 4 Differentially Regulate Signaling via the Gαq/11-Linked Muscarinic M3 Receptor , 2004, Molecular Pharmacology.

[14]  A. Levey,et al.  RGS2 Binds Directly and Selectively to the M1 Muscarinic Acetylcholine Receptor Third Intracellular Loop to Modulate Gq/11α Signaling* , 2004, Journal of Biological Chemistry.

[15]  J. Widom,et al.  Measurement of histone-DNA interaction free energy in nucleosomes. , 2004, Methods.

[16]  Wei Zhang,et al.  Differential Contribution of GTPase Activation and Effector Antagonism to the Inhibitory Effect of RGS Proteins on Gq-mediated Signaling in Vivo* , 2004, Journal of Biological Chemistry.

[17]  D. Lomas,et al.  Serpin identification, production, and characterization. , 2004, Methods.

[18]  R. Sunahara,et al.  Differentially Regulated Expression of Endogenous RGS4 and RGS7* , 2004, Journal of Biological Chemistry.

[19]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[20]  R. Soberman.  The expanding network of redox signaling: new observations, complexities, and perspectives. , 2003, The Journal of clinical investigation.

[21]  J. M. Wyss,et al.  Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. , 2003, The Journal of clinical investigation.

[22]  J. Hepler,et al.  Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling , 2002, Pharmacological Reviews.

[23]  R. Neubig,et al.  Receptor-selective Effects of Endogenous RGS3 and RGS5 to Regulate Mitogen-activated Protein Kinase Activation in Rat Vascular Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.

[24]  Y. Kubo,et al.  Alternative splicing of RGS8 gene determines inhibitory function of receptor type-specific Gq signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Neubig,et al.  ANG II type 1 receptor downregulation does not require receptor endocytosis or G protein coupling. , 2001, American journal of physiology. Cell physiology.

[26]  R. Neubig,et al.  Regulator of G protein signaling proteins: novel multifunctional drug targets. , 2001, The Journal of pharmacology and experimental therapeutics.

[27]  A. Varshavsky,et al.  RGS4 Is Arginylated and Degraded by the N-end Rule Pathway in Vitro * , 2000, The Journal of Biological Chemistry.

[28]  M. Linder,et al.  RGS4 Binds to Membranes through an Amphipathic α-Helix* , 2000, The Journal of Biological Chemistry.

[29]  E. Ross,et al.  Palmitoylation of a Conserved Cysteine in the Regulator of G Protein Signaling (RGS) Domain Modulates the GTPase-activating Activity of RGS4 and RGS10* , 1999, The Journal of Biological Chemistry.

[30]  D. Manning.  G Proteins , 1999 .

[31]  S. Muallem,et al.  RGS Proteins Determine Signaling Specificity of Gq-coupled Receptors* , 1999, The Journal of Biological Chemistry.

[32]  S. Muallem,et al.  The N-terminal Domain of RGS4 Confers Receptor-selective Inhibition of G Protein Signaling* , 1998, The Journal of Biological Chemistry.

[33]  A. Varshavsky,et al.  The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Blumer,et al.  RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunits , 1996, Nature.

[35]  S. Rees.  Signal Transduction - a Practical Approach. , 1994 .

[36]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[37]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[38]  T. K. Harden,et al.  Application of RGS box proteins to evaluate G-protein selectivity in receptor-promoted signaling. , 2004, Methods in enzymology.

[39]  T. L. Jones.  Role of palmitoylation in RGS protein function. , 2004, Methods in enzymology.

[40]  N. Lambert,et al.  Endogenous RGS proteins regulate presynaptic and postsynaptic function: functional expression of RGS-insensitive Galpha subunits in central nervous system neurons. , 2004, Methods in enzymology.

[41]  M. Sandberg,et al.  Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation , 2004, Nature.

[42]  E M Ross,et al.  GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. , 2000, Annual review of biochemistry.

[43]  M. Farquhar,et al.  The regulator of G protein signaling family. , 2000, Annual review of pharmacology and toxicology.

[44]  K. Blumer,et al.  RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. , 1996, Nature.

[45]  B. Marks.  Department of Pharmacology , 1969 .